Liang-I Kang, MD, PhD

Liang-I Kang, MD, PhD

Pathologist

Primary Academic Title

Assistant Professor of Pathology and Immunology, Anatomic and Molecular Pathology Liver & GI, WashU Medicine

Research Interest

Gastrointestinal pathology.

Education

  • 2013: PhD, cellular and molecular biology, University of Pittsburgh, PA
  • 2012: MD, University of Pittsburgh

Training

  • 2015 - 2018: Resident, anatomic pathology, Washington University, St. Louis
  • 2018 - 2019: Clinical fellow, liver and gastrointestinal pathology, Washington University

Board Certification

  • 2018: American Board of Pathology (Anatomic Pathology)

Selected Research Publications

Combined Flt3L and CD40 agonism restores dendritic cell-driven T cell immunity in pancreatic cancer.
  • Hogg GD, Weinstein AG, Kingston NL, [...] Kang LI, [...] DeNardo DG
  • Sci Immunol 2025
HMGA2 Expression Predicts Subtype, Survival, and Treatment Outcome in Pancreatic Ductal Adenocarcinoma.
  • Yamamoto N, Dobersch S, Loveless I, [...] Kang LI, [...] Kugel S
  • Clin Cancer Res 2025
Senescence Defines a Distinct Subset of Myofibroblasts That Orchestrates Immunosuppression in Pancreatic Cancer.
  • Belle JI, Sen D, Baer JM, [...] Kang LI, [...] DeNardo DG
  • Cancer Discov 2024
Tumor-associated fibrosis impairs immune surveillance and response to immune checkpoint blockade in non-small cell lung cancer.
  • Herzog BH, Baer JM, Borcherding N, [...] Kang LI, [...] DeNardo DG
  • Sci Transl Med 2023